D-dimer driven deep vein thrombosis prophylaxis strategy for hospitalized patients with COVID-19

Authors

Kristin Stawiarski, Section of Cardiovascular Medicine, Yale New Haven Health Bridgeport Hospital, United States of America. Electronic address: kristin.stawiarski@bpthosp.org.Follow
Ariane Loutoo, Section of Cardiovascular Medicine, Yale New Haven Health Bridgeport Hospital, United States of America.
Leah Velardi, Section of Cardiovascular Medicine, Yale New Haven Health Bridgeport Hospital, United States of America.
Stuart Zarich, Section of Cardiovascular Medicine, Yale New Haven Health Bridgeport Hospital, United States of America.

Document Type

Letter to the Editor

Publication Title

Thrombosis research

Abstract

COVID-19 induces a hypercoagulable state with early case reports of death from undetected venous thromboembolism. Various protocols and consensus statements have been proposed to address the optimal prophylaxis strategy for hospitalized patients. We offer our single institution experience with a d-dimer driven prophylaxis model with no deep vein thrombosis identified on discharge lower extremity ultrasounds.

First Page

151

Last Page

153

DOI

10.1016/j.thromres.2021.03.031

Publication Date

5-1-2021

Recommended Citation

Stawiarski, Kristin; Loutoo, Ariane; Velardi, Leah; and Zarich, Stuart, "D-dimer driven deep vein thrombosis prophylaxis strategy for hospitalized patients with COVID-19" (2021). Cardiology. 5.
https://scholar.bridgeporthospital.org/cardiology/5

Identifier

33862518 (pubmed); PMC8032599 (pmc); 10.1016/j.thromres.2021.03.031 (doi); S0049-3848(21)00136-5 (pii)